Algeria With non WTO members such as Algeria flouting intellectual property (IP) it raises the issue of how best to protect and price medicines in the future. In a fascinating interview we spoke to Rachid Kerrar from the Algerian firm Beker about their development of a cheaper, generic version of Gilead’s…
regulation Chinese ecommerce behemoths Alibaba and JD.com are being used to buy and sell tens of thousands of prescription medicines, skirting regulations in what is a legal grey area. According to a recent Financial Times report, dozens of listings from third party vendors – mainly pharmacies – for drugs such as…
Turkey With its current turbulent economic and political climate, Turkey is betting its future prosperity on 2 key aspects – its young talent pool and its location as an intersection between the West and the East. Hakan Yurdakul, head of economy monitoring and coordination at the Presidency Office is bullish, “The…
Hong Kong Laurence Frémy, director for APAC at Laboratoires Expanscience, discusses emerging skincare and dermatology trends in the region and her priorities for the affiliate. Having had the experience of opening the affiliate in Brazil, in addition to your in-depth understanding of other emerging markets, what were the key skills you…
Portugal Santiago Ruiz, entering his fourth year leading B. Braun’s Portuguese affiliate in Lisbon, highlights the innovation present in Portugal, B. Braun’s Vision 2020 and emerging trends in the medtech world. How has the affiliate evolved over the past three years under your management? We faced two crucial challenges over…
Hong Kong Zuellig Pharma’s Andi Umbricht discusses the distributor’s deep commitment to Asia, the adoption of new technologies, and emerging trends within the Hong Kong and Asian distribution markets. Zuellig Pharma has a long tradition in Asia. What capabilities have you developed over the years in the region? Zuellig Pharma started operations…
Algeria Mourad Belkheyar, acting director general of Varian Healthcare Algeria lifts the lid on the progress Algeria has made in its quest to bring the most advanced radiotherapies to Algeria. He discusses the critical role of Varian healthcare in training engineers, operating, and maintaining such complex machinery, to improve the prognosis…
Hong Kong Frederic Charles, CEO of Pierre Fabre Hong Kong and Macau, outlines brand perceptions of Pierre Fabre’s dermatological products in Hong Kong, e-commerce, and other emerging skincare trends in Asia. With the opening of Pierre Fabre Hong Kong affiliate in 2016, what were the main achievements so far? The affiliate…
France Dr. Denis Comet, President of AFCRO (the French Association of CROs), talks about the evolution of the clinical research environment in France and the new government actions aimed at speeding up the clinical trial process. Didier Genot from France Biotech told us that France has lost competitiveness when it…
Hong Kong Benjamin Chan of MediConcepts – a Hong Kong-based medtech CDMO – outlines the potential impact of the Greater Bay Area Initiative on Hong Kong medtech, and the key factors behind his company’s success. Benjamin, as an industry veteran within the Hong Kong medical devices sector, with also a factory…
France Didier Geneau provides a fascinating insight into the French biotech scene; its strengths but also weaknesses. France has an incredible track-record of excellence in innovation and, for the first time in a long time, true government backing. All the ingredients are there to excel even further in biotech innovation. Now,…
AstraZeneca Gwenael Meneux of AstraZeneca Hong Kong and Macau gives his initial impression of the HK market, outlines his unusual career trajectory and the new innovations AZ is looking to bring to patients in the region. Gwenael, you have a very interesting and diverse background that is a bit atypical…
See our Cookie Privacy Policy Here